Responses
Clinical science
Scientific reports
Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 22 March 2016
- Published on: 22 March 2016Investigating the response of periocular triamcinolone for Thyroid Associated Ophthalmopathy.Show More
Dear Editor
We read with interest the article by Ebner et al [1] investigating the efficacy of periocular triamcinolone for the treatment of Thyroid Associated Ophthalmopathy (TAO) and the presence of ocular or systemic adverse effects also previously published in 2001 [2]. The study used patients with TAO of less than 6 months duration previously untre...
Conflict of Interest:
None declared.